This is a classic presentation of complete androgen insensitivity syndrome (CAIS). The patient is genetically male (46,XY) and has functional testes that produce testosterone and Müllerian inhibitory factor (MIF). However, a defect in the androgen receptor prevents target tissues from responding to androgens. The presence of MIF causes regression of Müllerian structures (no uterus, fallopian tubes). The testosterone is aromatized to estrogen, leading to breast development. The lack of androgen effect explains the female external genitalia and absence of pubic/axillary hair.

This patient has androgen insensitivity syndrome (AIS). The 46,XY karyotype and presence of testes indicate genetic maleness. The testes produce both anti-Müllerian hormone (causing Müllerian duct regression) and testosterone. However, due to defective androgen receptors, testosterone and its metabolite DHT cannot exert their effects. This leads to a failure of virilization of the urogenital sinus, genital tubercle, and labioscrotal folds, which then develop along the default female pathway, resulting in female external genitalia.

The patient's presentation of short stature, delayed bone age, low IGF-1, and a blunted response to GH stimulation testing is classic for growth hormone deficiency. Growth hormone is produced and secreted by the somatotroph cells of the anterior pituitary. Therefore, dysfunction of the anterior pituitary is the most likely cause.

This patient has 5-alpha-reductase deficiency, an autosomal recessive disorder affecting 46,XY individuals. This enzyme is responsible for converting testosterone to the more potent dihydrotestosterone (DHT). DHT is required for the development of the external male genitalia in utero. Its deficiency leads to ambiguous or female-like external genitalia at birth. At puberty, the surge in testosterone can induce virilization, causing phallic growth, voice deepening, and muscle development.

This patient's constellation of symptoms, including diabetes mellitus, weight loss, diarrhea, and the characteristic skin rash known as necrolytic migratory erythema, is classic for glucagonoma syndrome. This is caused by a glucagon-secreting tumor of the pancreatic alpha cells. The diagnosis is confirmed by a markedly elevated serum glucagon level.

This patient presents with Laron syndrome, a form of dwarfism characterized by growth hormone insensitivity. It is caused by a defect in the growth hormone receptor. The anterior pituitary produces adequate or even excessive GH, but the target tissues (primarily the liver) cannot respond to it. This leads to a failure to produce IGF-1, resulting in short stature despite high GH levels. The lack of negative feedback from IGF-1 on the pituitary leads to the elevated GH.

This patient has central precocious puberty, also known as gonadotropin-dependent precocious puberty. The key diagnostic finding is the pubertal response (a significant rise in LH and FSH) to a GnRH stimulation test. This indicates that the hypothalamic-pituitary-gonadal (HPG) axis has been prematurely activated, leading to the early onset of puberty. It is often idiopathic in girls but can be caused by CNS lesions.

The combination of hypogonadotropic hypogonadism (delayed puberty with low LH and FSH) and anosmia (lack of smell) is characteristic of Kallmann syndrome. This genetic disorder results from the failed migration of GnRH-releasing neurons from their origin in the olfactory placode to their final destination in the hypothalamus during embryonic development. This leads to a deficiency of GnRH and subsequent failure to initiate puberty.

This patient's presentation of delayed puberty, short stature for chronological age, delayed bone age, and a positive family history is classic for constitutional delay of growth and puberty. This is a common, benign variant of normal development where the tempo of growth and maturation is slower, but eventual adult height and sexual development are normal.

The clinical features described—tall stature with eunuchoid proportions, gynecomastia, and small, firm testes—are characteristic of Klinefelter syndrome. This genetic disorder is caused by the presence of an extra X chromosome in males, resulting in a 47,XXY karyotype. The condition leads to primary hypogonadism with testicular atrophy, low testosterone, and elevated gonadotropins (hypergonadotropic hypogonadism).